Ovid Therapeutics Inc. (OVID) earnings date
Mar 12, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 40% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 44 days, typically, give or take 16 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Nov 10, 2026 | before open | 41 | 8-K |
| Q4 FY2025 | Wed, Mar 18, 2026 | before open | 77 | 8-K |
| Q3 FY2025 | Wed, Nov 12, 2025 | before open | 43 | 8-K |
| Q1 FY2025 | Tue, May 13, 2025 | before open | 43 | 8-K |
| Q4 FY2024 | Tue, Mar 11, 2025 | before open | 70 | 8-K |
| Q1 FY2024 | Tue, May 14, 2024 | before open | 44 | 8-K |
| Q4 FY2023 | Fri, Mar 8, 2024 | before open | 68 | 8-K |
| Q3 FY2023 | Fri, Nov 3, 2023 | before open | 34 | 8-K |
What they guided beta
| Q3 FY2026 | "OV329 is advancing in a global, Phase 2 focal epilepsy study expected to read out in H2 2027" exhibit |
| Q3 FY2026 | "Ovid is enrolling patients in ongoing photosensitivity study intended to demonstrate the anticonvulsant effect of OV329; results expected in early 2027" exhibit |
| Q3 FY2026 | "Cash, cash equivalents and marketable securities were $161.4 million as of September 30, 2026; expected financial runway into 2029 NEW YORK, November 10, 2026 – Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company dedicated to pioneering better, gentler medicines for brain disorders with significant unmet need, today provided business updates including financial results for the third quarter ended September 30, 2026." exhibit |
| Q3 FY2026 | "“We anticipate findings from two high potential programs in early 2027, which may respectively demonstrate the broad potential of KCC2 direct activation and the anticonvulsant profile of OV329, a next-generation GABA-AT inhibitor." exhibit |
| Q3 FY2026 | "The study is enrolling, and Ovid anticipates reading out topline data in the first quarter of 2027." exhibit |
| Q4 FY2025 | "$90.4 million in cash, cash equivalents and marketable securities as of December 31, 2025, expected to fund key studies for OV329 and OV4071 and operations into late 2028; exercise of outstanding warrants may further extend runway into 2029" exhibit |
| Q4 FY2025 | "Ovid is engaged in regulatory conversations and currently anticipates initiating the Phase 2 study in the second quarter of 2026." exhibit |
| Q4 FY2025 | "The Company will be hosting an R&D Day dedicated to the KCC2 portfolio on April 14, 2026." exhibit |
| Q4 FY2025 | "If all Series A Warrants are exercised in full, the Company anticipates receiving up to an additional $53.9 million in gross proceeds, prior to deducting placement agent fees, potentially extending Ovid’s cash runway into 2029." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/OVID
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/OVID
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/OVID/"><img src="https://veritasdata.dev/embed/OVID.svg" alt="OVID earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/OVID/)
Script
<script async src="https://veritasdata.dev/embed/OVID.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/OVID"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.